After CRISPR/Cas9 makes a double-strand break in DNA and the cell repairs it, the same set of mutations crop up again and again based on the genomic sequence.
The company emerged from stealth mode this month and traces roots to both rocket maker SpaceX and the shuttered sequencing company Halcyon Molecular.
The new method takes expressed mRNA and turns it into guide sequences for CRISPR/Cas9 knockout screening when bioinformatics-based design isn't an option.
The contract research organization said it has already used CRISPR/Cas9 editing in several customer projects and also plans to use it for internal R&D.
Scientists introduced an indel to a promoter region to mimic a benign, naturally-occurring mutation that activated fetal hemoglobin production.
Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.
DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, the New York Times reports.
A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.
In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.